1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Illinois >
  6. Integra LifeSciences Acquires SIA

M&A Deal Summary

Integra LifeSciences Acquires SIA

On December 1, 2022, Integra LifeSciences acquired medical products company SIA

Acquisition Highlights
  • This is Integra LifeSciences’ 37th transaction in the Medical Products sector.
  • This is Integra LifeSciences’ 37th transaction in the United States.
  • This is Integra LifeSciences’ 1st transaction in Illinois.

M&A Deal Summary
Date 2022-12-01
Target SIA
Sector Medical Products
Buyer(s) Integra LifeSciences
Deal Type Add-on Acquisition
Advisor(s) BofA Securities (Financial)
Proskauer Rose (Legal)

Target

SIA

Chicago, Illinois, United States
SIA is a commercial-stage medical device company, committed to raising the standard of care in plastic, reconstructive, and general surgery and lowering systemic costs through “for surgeon, by surgeon” medical device innovation. The company’s flagship product family, DuraSorb Monofilament Mesh is on the market and indicated for use in the reinforcement of soft tissues where weakness exists. DuraSorb was specifically designed for plastic, reconstructive, and general surgery and is US FDA 510(k) cleared and CE marked. SIA was formed in 2016 and is based in Chicago, Illinois.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Integra LifeSciences

Princeton, New Jersey, United States
Category Company
Founded 1989
Sector Medical Products
Employees4,396
Revenue 1.6B USD (2024)
DESCRIPTION

Integra LifeSciences is a major medical technology dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra LifeSciences was founded in 1989 and is based in Princeton, New Jersey.

DEAL STATS #
Overall 44 of 45
Sector: Medical Products M&A 37 of 38
Type: Add-on Acquisition M&A Deals 33 of 33
State: Illinois M&A 1 of 1
Country: United States M&A 37 of 38
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-16 ACell

Columbia, Maryland, United States

ACell, Inc. is a medicine company focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. ACell’s core product portfolio is based on our platform MatriStem UBM™ technology. Acell was founded in 2002 and is based in Columbia, Maryland.

Buy $400M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-13 Acclarent

Menlo Park, California, United States

Acclarent is a medical device company dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. It has developed the Balloon Sinuplasty system: a novel, endoscopic, catheter-based technology used by surgeons for sinusitis patients. Acclarent was formed in 2004 and is based in Menlo Park, California.

Buy $275M
Mergr

Solution for

Product

Company

Legal